 |
 |
 |
 |
 |
 |
 |
 |
 |  | Developing minimally-invasive drug-device convergence products for localized drug delivery
|  | Private
|  | 2009
|
 |
 |  | Developing incision-less vision correction procedures
|  | Private
|  | 2009
|
 |
 |  | Developing on-body health awareness products
|  | Private
|  | 2007
|
 |
 |  | Developing sensitive, precise and robust platform for single molecule analysis
|  | Private
|  | 2007
|
 |
 |  | Developing transformative in vitro and in vivo diagnostic products
|  | Private
|  | 2006
|
 |
 |  | Develops real-time tools to monitor thermal ablation of tumors
|  | Private
|  | 2005
|
 |
 |  | Developing in vivo molecular imaging systems to detect and treat disease
|  | Private
|  | 2005
|
 |
 |  | Developing platform to synthesize compounds for drug discovery and biodetection
|  | Private
|  | 2004
|
 |
 |  | Developing cell-based therapies that induce repair and regeneration in a wide array of tissues
|  | Private
|  | 2003
|
 |
 |  | Developing high throughput, single-molecule DNA sequencing platform
|  | Public (Nasdaq: HLCS)
|  | 2003
|
 |
 |  | Developing systems to prolong the health of transplantation organs
|  | Private
|  | 2003
|
 |
 |  | Developing tools and technologies applying systems biology to drug discovery and development
|  | Private
|  | 2000
|
 |